In my last post, I focused on flaws in the medical device approval process. The Union of Concerned Scientists' "FDA at a Crossroads" meeting also covered problems with drug approval.
News is rapidly changing regarding Ebola. Even as I've been writing this post, we've gone from "There is no treatment except supportive care" to NIH's Dr.
Last month, the Food and Drug Administration proposed changing Nutrition Facts labels to make serving sizes reflect what people actually eat.
The agency has proposed the $3 billion industry should show proof behind their advertising
A reproductive technology that taps three parents’ DNA as a way to eliminate hereditary diseases could reach clinical trials if the Food and Drug Administration gives the go-ahead
Last spring, I wrote a blog post for Scientific American's guest blog about gluten sensitivity, a condition in which patients without celiac disease exhibit symptoms, such as bloating or fatigue, that improve with a gluten-free diet.
Have you ever wondered about the medicines you take—how they are developed and produced? We'll explore that in "Molecules to Medicine." This new series could be described as "medicine for muggles," intended to take the mystery out of clinical research and drug development and to provide background information so that both patients and physicians can [...]
Imagine if in the 1960s surgeons like Christiaan Barnard or Norman Shumway had had to use the same rules that govern the development and testing of pharmaceutical medications when they were teaching the rest of the world how to transplant hearts from the recently deceased into their patients.
Scientists at the U.S. Food and Drug Administration have found that bisphenol A does not affect the health of rats fed low doses. Other scientists say the study is flawed
We looked briefly at why drug studies came into being; now let's look at how a drug is developed, from test tube to your tissues. Every government approved drug goes through the same sequence of testing anywhere in the world.
Any confusion over the recent news of cholesterol guidelines in the U.S. is perfectly understandable. On the one hand, the guidelines suggest that nearly half the population should use statins to stave off heart attacks and strokes.
A few techno-libertarians are up in arms over the FDA’s letter warning the genetics company 23andme to stop selling its personalized genome services kit.
Even without tobacco, the poorly regulated devices may pose unique dangers
I took a field trip to the big city last week, to attend the Union of Concerned Scientists' and George Washington University School of Public Health's conference, "FDA at a Crossroads." I have great respect for UCS and their efforts to keep science depoliticized, a topic that I have written and spoken about.
I grabbed a box of cereal out of my cabinet. The flakes smelled stale, but I was hungry enough. I poured a cup or two into a bowl, followed by a splash of milk.
Just last week, I mentioned that Eli Lilly and Company, as a condition of approval for their blockbuster drug, was required to conduct post-marketing studies of Xigris.